Previous studies showed that up-regulation of lipocalin-2 in SLE can promote the in vivo and in vitro differentiation of Th1 cells via the IL-12/STAT4 signalling pathway, thereby causing an immune imbalance and leading to lupus nephritis (LN) (Chen et al., 2020). Here, STAT4 is linked to lobular neoplasia.